Europe and Norway discuss improving affordable access to innovative medicines

WHO

16 January 2020 - All countries across the WHO European Region face a challenge in ensuring that high-value but expensive medicines are available in a sustainable way to people who could benefit from them.

At the World Health Assembly in May 2019, Member States adopted resolution WHA72.8 on improving the transparency of markets for medicines, vaccines and other health products. This resolution seeks to enhance public sharing of information on prices paid by governments and other buyers for health products, while providing greater transparency on pharmaceutical patents, clinical trial results and other factors affecting pricing.

During a high-level WHO/Europe visit to Norway on 8 January 2020, Mr Bent Høie, Minister of Health and Care Services of Norway, called on WHO/Europe to take a leading convening role to push further collaboration in this area.

Read WHO press release

Michael Wonder

Posted by:

Michael Wonder